Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study

Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study

Background: Defining clinical and subclinical progression in multiple sclerosis (MS) is challenging. Patient history, expanded disability status scale (EDSS), and magnetic resonance imaging (MRI) all have shortcomings and may underestimate disease dynamics. Emerging serum biomarkers such as glial fi...

Full description

Bibliographic Details
Main Authors: Ahmed Abdelhak, Andre Huss, Alexander Stahmann, Makbule Senel, Markus Krumbholz, Markus C. Kowarik, Joachim Havla, Tania Kümpfel, Ingo Kleiter, Isabella Wüstinger, Uwe K. Zettl, Margit Schwartz, Romy Roesler, Tim Friede, Albert C. Ludolph, Ulf Ziemann, Hayrettin Tumani
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:Contemporary Clinical Trials Communications
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865420300582

Internet

http://www.sciencedirect.com/science/article/pii/S2451865420300582

Similar Items